(ABEV) Ambev - Overview
Exchange: NYSE •
Country: Brazil •
Currency: USD •
Type: Common Stock •
ISIN: US02319V1035
Stock: Beer, Soft Drinks, Water, Juices, Energy Drinks
Total Rating 64
Risk 92
Buy Signal 0.32
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 8.70% |
| Yield on Cost 5y | 9.23% |
| Yield CAGR 5y | 13.20% |
| Payout Consistency | 83.4% |
| Payout Ratio | 63.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 25.6% |
| Relative Tail Risk | -1.01% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.83 |
| Alpha | 57.70 |
| Character TTM | |
|---|---|
| Beta | 0.355 |
| Beta Downside | 0.095 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.91% |
| CAGR/Max DD | 0.27 |
Description: ABEV Ambev January 28, 2026
Ambev S.A. (NYSE: ABEV) is a Brazil-based beverage conglomerate that produces, distributes, and sells a broad portfolio of alcoholic and non-alcoholic drinks-including beer (Brahma, Skol, Antarctica), soft drinks, bottled water, energy drinks, juices, and ready-to-drink teas-across Brazil, Central America, the Caribbean, Latin America South, and Canada, leveraging both its own brands and licensed international labels such as Budweiser, Corona, and Red Bull.
Key recent metrics: 2025 net revenue grew 5.2% YoY to US$ 15.8 billion, driven by a 3.8% rise in per-capita beer consumption in Brazil and a 7% expansion of its premium-segment share; operating margin improved to 18.1% as the company trimmed logistics costs after a 12% reduction in diesel prices. Macro-wise, Brazil’s real GDP is projected to expand 2.3% in 2026, while inflationary pressure on raw-material inputs (barley, aluminum) is expected to ease, supporting margin stability for brewers.
For a deeper, data-rich valuation perspective, you may want to explore the analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 16.04b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 0.63 > 1.0 |
| NWC/Revenue: 5.93% < 20% (prev 8.49%; Δ -2.57% < -1%) |
| CFO/TA 0.18 > 3% & CFO 25.09b > Net Income 16.04b |
| Net Debt (-15.41b) to EBITDA (29.96b): -0.51 < 3 |
| Current Ratio: 1.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (15.67b) vs 12m ago -0.91% < -2% |
| Gross Margin: 51.77% > 18% (prev 0.51%; Δ 5126 % > 0.5%) |
| Asset Turnover: 62.82% > 50% (prev 55.95%; Δ 6.87% > 0%) |
| Interest Coverage Ratio: 15.14 > 6 (EBITDA TTM 29.96b / Interest Expense TTM 1.51b) |
Altman Z'' 5.26
| A: 0.04 (Total Current Assets 41.94b - Total Current Liabilities 36.58b) / Total Assets 140.75b |
| B: 0.05 (Retained Earnings 7.43b / Total Assets 140.75b) |
| C: 0.16 (EBIT TTM 22.90b / Avg Total Assets 144.02b) |
| D: 3.59 (Book Value of Equity 172.61b / Total Liabilities 48.03b) |
| Altman-Z'' Score: 5.26 = AAA |
Beneish M -2.77
| DSRI: 1.33 (Receivables 8.88b/6.09b, Revenue 90.47b/82.41b) |
| GMI: 0.98 (GM 51.77% / 50.98%) |
| AQI: 1.00 (AQ_t 0.51 / AQ_t-1 0.51) |
| SGI: 1.10 (Revenue 90.47b / 82.41b) |
| TATA: -0.06 (NI 16.04b - CFO 25.09b) / TA 140.75b) |
| Beneish M-Score: -2.77 (Cap -4..+1) = A |
What is the price of ABEV shares?
As of February 02, 2026, the stock is trading at USD 2.78 with a total of 29,532,658 shares traded.
Over the past week, the price has changed by -0.71%, over one month by +12.55%, over three months by +24.98% and over the past year by +64.34%.
Over the past week, the price has changed by -0.71%, over one month by +12.55%, over three months by +24.98% and over the past year by +64.34%.
Is ABEV a buy, sell or hold?
Ambev has received a consensus analysts rating of 3.42.
Therefor, it is recommend to hold ABEV.
- StrongBuy: 2
- Buy: 2
- Hold: 7
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the ABEV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2.9 | 5.4% |
| Analysts Target Price | 2.9 | 5.4% |
| ValueRay Target Price | 3.4 | 23% |
ABEV Fundamental Data Overview January 27, 2026
Market Cap BRL = 229.49b (43.65b USD * 5.2571 USD.BRL)
P/E Trailing = 13.9
P/E Forward = 14.2045
P/S = 0.4825
P/B = 2.494
P/EG = 1.4792
Revenue TTM = 90.47b BRL
EBIT TTM = 22.90b BRL
EBITDA TTM = 29.96b BRL
Long Term Debt = 264.1m BRL (from longTermDebt, last quarter)
Short Term Debt = 1.05b BRL (from shortTermDebt, last quarter)
Debt = 2.90b BRL (from shortLongTermDebtTotal, last quarter)
Net Debt = -15.41b BRL (from netDebt column, last quarter)
Enterprise Value = 212.54b BRL (229.49b + Debt 2.90b - CCE 19.84b)
Interest Coverage Ratio = 15.14 (Ebit TTM 22.90b / Interest Expense TTM 1.51b)
EV/FCF = 10.31x (Enterprise Value 212.54b / FCF TTM 20.61b)
FCF Yield = 9.70% (FCF TTM 20.61b / Enterprise Value 212.54b)
FCF Margin = 22.78% (FCF TTM 20.61b / Revenue TTM 90.47b)
Net Margin = 17.73% (Net Income TTM 16.04b / Revenue TTM 90.47b)
Gross Margin = 51.77% ((Revenue TTM 90.47b - Cost of Revenue TTM 43.64b) / Revenue TTM)
Gross Margin QoQ = 51.46% (prev 49.99%)
Tobins Q-Ratio = 1.51 (Enterprise Value 212.54b / Total Assets 140.75b)
Interest Expense / Debt = 24.85% (Interest Expense 719.7m / Debt 2.90b)
Taxrate = 6.72% (350.2m / 5.21b)
NOPAT = 21.36b (EBIT 22.90b * (1 - 6.72%))
Current Ratio = 1.15 (Total Current Assets 41.94b / Total Current Liabilities 36.58b)
Debt / Equity = 0.03 (Debt 2.90b / totalStockholderEquity, last quarter 92.03b)
Debt / EBITDA = -0.51 (Net Debt -15.41b / EBITDA 29.96b)
Debt / FCF = -0.75 (Net Debt -15.41b / FCF TTM 20.61b)
Total Stockholder Equity = 94.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.14% (Net Income 16.04b / Total Assets 140.75b)
RoE = 16.99% (Net Income TTM 16.04b / Total Stockholder Equity 94.42b)
RoCE = 24.19% (EBIT 22.90b / Capital Employed (Equity 94.42b + L.T.Debt 264.1m))
RoIC = 22.20% (NOPAT 21.36b / Invested Capital 96.24b)
WACC = 7.42% (E(229.49b)/V(232.38b) * Re(7.22%) + D(2.90b)/V(232.38b) * Rd(24.85%) * (1-Tc(0.07)))
Discount Rate = 7.22% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.50%
[DCF Debug] Terminal Value 81.53% ; FCFF base≈20.62b ; Y1≈22.72b ; Y5≈29.23b
Fair Price DCF = 37.54 (EV 570.77b - Net Debt -15.41b = Equity 586.18b / Shares 15.62b; r=7.42% [WACC]; 5y FCF grow 11.74% → 2.90% )
EPS Correlation: 16.87 | EPS CAGR: -46.96% | SUE: -1.02 | # QB: 0
Revenue Correlation: 37.11 | Revenue CAGR: -1.44% | SUE: -0.03 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.05 | Chg30d=N/A | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=0.19 | Chg30d=-0.000 | Revisions Net=-1 | Growth EPS=+5.9% | Growth Revenue=+5.0%
P/E Trailing = 13.9
P/E Forward = 14.2045
P/S = 0.4825
P/B = 2.494
P/EG = 1.4792
Revenue TTM = 90.47b BRL
EBIT TTM = 22.90b BRL
EBITDA TTM = 29.96b BRL
Long Term Debt = 264.1m BRL (from longTermDebt, last quarter)
Short Term Debt = 1.05b BRL (from shortTermDebt, last quarter)
Debt = 2.90b BRL (from shortLongTermDebtTotal, last quarter)
Net Debt = -15.41b BRL (from netDebt column, last quarter)
Enterprise Value = 212.54b BRL (229.49b + Debt 2.90b - CCE 19.84b)
Interest Coverage Ratio = 15.14 (Ebit TTM 22.90b / Interest Expense TTM 1.51b)
EV/FCF = 10.31x (Enterprise Value 212.54b / FCF TTM 20.61b)
FCF Yield = 9.70% (FCF TTM 20.61b / Enterprise Value 212.54b)
FCF Margin = 22.78% (FCF TTM 20.61b / Revenue TTM 90.47b)
Net Margin = 17.73% (Net Income TTM 16.04b / Revenue TTM 90.47b)
Gross Margin = 51.77% ((Revenue TTM 90.47b - Cost of Revenue TTM 43.64b) / Revenue TTM)
Gross Margin QoQ = 51.46% (prev 49.99%)
Tobins Q-Ratio = 1.51 (Enterprise Value 212.54b / Total Assets 140.75b)
Interest Expense / Debt = 24.85% (Interest Expense 719.7m / Debt 2.90b)
Taxrate = 6.72% (350.2m / 5.21b)
NOPAT = 21.36b (EBIT 22.90b * (1 - 6.72%))
Current Ratio = 1.15 (Total Current Assets 41.94b / Total Current Liabilities 36.58b)
Debt / Equity = 0.03 (Debt 2.90b / totalStockholderEquity, last quarter 92.03b)
Debt / EBITDA = -0.51 (Net Debt -15.41b / EBITDA 29.96b)
Debt / FCF = -0.75 (Net Debt -15.41b / FCF TTM 20.61b)
Total Stockholder Equity = 94.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.14% (Net Income 16.04b / Total Assets 140.75b)
RoE = 16.99% (Net Income TTM 16.04b / Total Stockholder Equity 94.42b)
RoCE = 24.19% (EBIT 22.90b / Capital Employed (Equity 94.42b + L.T.Debt 264.1m))
RoIC = 22.20% (NOPAT 21.36b / Invested Capital 96.24b)
WACC = 7.42% (E(229.49b)/V(232.38b) * Re(7.22%) + D(2.90b)/V(232.38b) * Rd(24.85%) * (1-Tc(0.07)))
Discount Rate = 7.22% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.50%
[DCF Debug] Terminal Value 81.53% ; FCFF base≈20.62b ; Y1≈22.72b ; Y5≈29.23b
Fair Price DCF = 37.54 (EV 570.77b - Net Debt -15.41b = Equity 586.18b / Shares 15.62b; r=7.42% [WACC]; 5y FCF grow 11.74% → 2.90% )
EPS Correlation: 16.87 | EPS CAGR: -46.96% | SUE: -1.02 | # QB: 0
Revenue Correlation: 37.11 | Revenue CAGR: -1.44% | SUE: -0.03 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.05 | Chg30d=N/A | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=0.19 | Chg30d=-0.000 | Revisions Net=-1 | Growth EPS=+5.9% | Growth Revenue=+5.0%